The PMDA provides details for remote inspections known as compliance inspections.
The PMDA conducts the following compliance inspections:
Document-based inspection and GCP on-site inspection for approval of drugs and regenerative medical products
Document-based inspection and GPSP on-site inspection for interim evaluation, reexamination, and reevaluation of drugs
Document-based inspection and GPSP on-site inspection for approval review after conditional and time-limited authorization, reexamination, and reevaluation of regenerative medical products